Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia
説明
<jats:title>Abstract</jats:title><jats:p>Besides the conventional carbon sources, acetyl-CoA has recently been shown to be generated from acetate in various types of cancers, where it promotes lipid synthesis and tumour growth. The underlying mechanism, however, remains largely unknown. We find that acetate induces a hyperacetylated state of histone H3 in hypoxic cells. Acetate predominately activates lipogenic genes <jats:italic>ACACA</jats:italic> and <jats:italic>FASN</jats:italic> expression by increasing H3K9, H3K27 and H3K56 acetylation levels at their promoter regions, thus enhancing <jats:italic>de novo</jats:italic> lipid synthesis, which combines with its function as the metabolic precursor for fatty acid synthesis. Acetyl-CoA synthetases (ACSS1, ACSS2) are involved in this acetate-mediated epigenetic regulation. More importantly, human hepatocellular carcinoma with high ACSS1/2 expression exhibit increased histone H3 acetylation and FASN expression. Taken together, this study demonstrates that acetate, in addition to its ability to induce fatty acid synthesis as an immediate metabolic precursor, also functions as an epigenetic metabolite to promote cancer cell survival under hypoxic stress.</jats:p>
収録刊行物
-
- Nature Communications
-
Nature Communications 7 (1), 11960-, 2016-06-30
Springer Science and Business Media LLC
